1-20 of 44
Depei Wu, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential CD19- and Bcma-Specific Chimeric Antigen Receptor T Cell Treatment for RRMM: Report from a Single Center Study

Lingzhi Yan, Zhi Yan, Jingjing Shang, Xiaolan Shi, Song Jin, Liqing Kang, Su Qu, Jin Zhou, Huizhu Kang, Ruju Wang, Ying Yao, Jing Wang, Weiqin Yao, Guanghua Chen, Lei Yu, Depei Wu, MD PhD, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 578.
https://doi.org/10.1182/blood-2019-129740
Published: 2019
Journal Articles

Combined Infusion of Anti-CD19 and Anti-Bcma CART Cells after Early or Later Transplantation in the Front Line Was Superior to Salvage Therapy for High Risk MM

Xiaolan Shi, Lingzhi Yan, Jingjing Shang, Liqing Kang, Song Jin, Huizhu Kang, Ruju Wang, Zhu Mingqing, Jiazi Zhou, Feiran Gong, Guanghua Chen, Jin Zhou, Huirong Chang, Weiqin Yao, Ying Yao, Yong Liu, Zhi Yan, Juanjuan Su, Depei Wu, MD PhD, Lei Yu, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1949.
https://doi.org/10.1182/blood-2019-131546
Published: 2019
Journal Articles

Allogeneic Stem Cell Transplantation Combined with Mesenchymal Stem Cells Transfusion in Primary Myelofibrosis-a Single-Center Retrospective Study

Qingyuan Wang, MD, Limin Liu, MD PhD, Huifen Zhou, Miao Miao, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2054.
https://doi.org/10.1182/blood-2019-130572
Published: 2019
Journal Articles

Tandem CAR T Cells Targeting CD19 and CD22 Is a Safe and Highly Efficacious Treatment for Relapse/ Refractory ALL Patients

Xiaowen Tang, Liqing Kang, Wei Qi, Wei Cui, Haiping Dai, Zheng Li, Jia Yin, Changju Qu, PhD, Ting Xu, Xiaming Zhu, Lei Yu, MD PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1338.
https://doi.org/10.1182/blood-2019-127890
Published: 2019
Journal Articles

Initial Safety and Efficacy of Dose-Escalating HDACs Inhibitor Chidamide with VRD (Chi-VRD) Treatment for Newly-Diagnosed High-Risk Transplant Eligible Multiple Myeloma Patients

Jingjing Shang, Weiqin Yao, Lingzhi Yan, Xiaolan Shi, Ruju Wang, Shuang Yan, Yong Liu, Depei Wu, MD PhD, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1855.
https://doi.org/10.1182/blood-2019-129434
Published: 2019
Journal Articles

Outcome of Autologous Hematopoietic Cell Transplantation in First Complete Remission(CR1) in Patients with Peripheral T-Cell Lymphomas(PTCLs)

Shuo Liu, Zhengming Jin, Depei Wu, MD PhD, Haiwen Huang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3315.
https://doi.org/10.1182/blood-2019-125666
Published: 2019
Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation Compared with HLA-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Haiwen Huang, MD PhD, Qian Zhu, Lihong Zhang, Shuo Liu, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4610.
https://doi.org/10.1182/blood-2019-125832
Published: 2019
Journal Articles

Impact of FLT3 -ITD Remission Depth in Acute Myeloid Leukemia Patients Prognosis Prediction before Allogeneic Hematopoietic Cell Transplantation

Xiaoyu Xu, Hongjie Shen, Jia Chen, Xiaowen Tang, Shengli Xue, Xu Yang, Qiaocheng Qiu, Zixuan Ding, Suning Chen, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 262.
https://doi.org/10.1182/blood-2019-130381
Published: 2019
Journal Articles

Cellular Kinetics of CD19 Chimeric Antigen Receptor T Cells in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma

Caixia Li, Changfeng Zhang, PhD, Ying Zhang, Xiaoyan Lou, Jinfang Zhang, Jia Chen, MD, Xiaochen Chen, Liqing Kang, Jin Zhou, Xiangping Zong, Zhen Yang, Jiaqi Li, Wei Qi, Lei Yu, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4097.
https://doi.org/10.1182/blood-2019-127928
Published: 2019
Journal Articles

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients in China in the Rituximab Era

Yun Li, MD PhD, Meng Wu, MD, Huiqiang Huang, MD PhD, Wei Xu, MD PhD, Haiwen Huang, MD PhD, Weili Zhao, MD PhD, Yanyan Wang, MD, Shuo Liu, MD, Pengpeng Xu, MD, Zhengming Chen, Yuqin Song, MD PhD, Jia Ruan, MD PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3994.
https://doi.org/10.1182/blood-2019-125192
Published: 2019
Journal Articles

Successful Treatment of Chimeric Antigen Receptor T Cell Therapy in Refractory or Relapsed Acute Leukemia Patients with TP53 alterations

Changju Qu, PhD, Jia Yin, Liqing Kang, Zheng Li, Haiping Dai, Xiaming Zhu, Lei Yu, Depei Wu, MD PhD, Xiaowen Tang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3822.
https://doi.org/10.1182/blood-2019-128013
Published: 2019
Journal Articles

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Abdul Hamid Bazarbachi, MD, Rama Al Hamed, MD, Myriam Labopin, MD, Kazimierz Halaburda, MD PhD, Hélène Labussière-Wallet, Paolo Bernasconi, MD, Wilfried Schroyens, MD PhD, Virginie Gandemer, MD PhD, Nicolaas Schaap, MD PhD, Pierre Simon Rohrlich, MD PhD, Pavel Jindra, MD PhD, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Depei Wu, MD PhD, Blandine Guffroy, Montserrat Rovira, MD, Sylvain Chantepie, MD, Xavier Poire, Dolores Caballero, MD PhD, Emmanouil Nikolousis, Mario Petrini, MD PhD, Fabio Ciceri, MD, Frédéric Baron, MD PhD, Ali Bazarbachi, MD PhD, Selim Corbacioglu, MD, Bipin N. Savani, MD, Zinaida Peric, MD PhD, Arnon Nagler, MD MSc, Enric Carreras, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4483.
https://doi.org/10.1182/blood-2019-124065
Published: 2019
Journal Articles

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Changju Qu, PhD, Nana Ping, MD, PhD, Danqing Kong, MD, Fan Xia, MD, Depei Wu, MD PhD, Zhengming Jin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5338.
https://doi.org/10.1182/blood-2019-128111
Published: 2019
Journal Articles

Relative Depletion of Soluble Interleukin 6 Receptors Abolished the Development of Cytokine Release Syndrome after CART19/22 and Lenalidomide Treatment for Lymphoma

Caixia Li, Changfeng Zhang, PhD, Xiaochen Chen, Ying Zhang, Jia Chen, MD, Liqing Kang, Xiaoyan Lou, Jin Zhou, Xiangping Zong, Zhen Yang, Jiaqi Li, Wei Qi, Lei Yu, Depei Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5313.
https://doi.org/10.1182/blood-2019-126821
Published: 2019
Journal Articles

Outcomes of Haploidentical Haematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Haemoglobinuria

Limin Liu, MD PhD, Huifen Zhou, Miao Miao, Depei Wu, MD PhD, Xiaowen Tang, Huiying Qiu, PhD, Yue Han, MD, Zhengming Jin, MD, Suning Chen, Aining Sun, PhD, Qingyuan Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5730.
https://doi.org/10.1182/blood-2019-131808
Published: 2019
Journal Articles

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, MD, Jian Zhang, MD, Jia Chen, MD, Zhenkun Wang, PhD, Caixia Li, Fu Cheng Cheng, MD PhD, Depei Wu, MD PhD, Lei Yu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2621.
https://doi.org/10.1182/blood-2019-132067
Published: 2019
Journal Articles

Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Xiaowen Tang, Benigno C. Valdez, PhD, Qianqian Zhang, Yunju Ma, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, MD PhD, Jia Chen, Xiaming Zhu, Depei Wu, MD PhD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3270.
https://doi.org/10.1182/blood-2019-123951
Published: 2019
Journal Articles

Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia

Yunju Ma, Changju Qu, PhD, Haiping Dai, Jia Yin, Zheng Li, Jia Chen, Huiying Qiu, Aining Sun, PhD, Miao Miao, Chengcheng Fu, Zhengming Jin, MD, Xiaming Zhu, Depei Wu, MD PhD, Xiaowen Tang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3306.
https://doi.org/10.1182/blood-2019-124033
Published: 2019
Journal Articles

Histopathology of Chronic Kidney Disease after Allogeneic Hematopoietic Cell Transplantation: A Multi-Center Observational Study of Kidney Biopsies

Feng Chen, MD PhD, Depei Wu, MD PhD, Ran Wang, MD, Xianghua Huang, MD PhD, Xiaozhong Li, MD PhD, Chaoxing Huang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5696.
https://doi.org/10.1182/blood-2019-128121
Published: 2019
Journal Articles

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Mohamed A Yassin, Ali Taher, MD PhD, Vikram Mathews, MD, Hsin-An Hou, MD PhD, Tahir Shamsi, Tulin Tuglular, MD, Zhijian Xiao, Soo-Jeong Kim, MD, Depei Wu, MD PhD, Junmin Li, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5461.
https://doi.org/10.1182/blood-2018-99-114416
Published: 2018